Company Filing History:

36 out of 4,770

Merck + Co., Inc.

1 out of 832,680

Other

patents

Years Active: 1981-2003

Loading Chart...

38 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 6566385 - Inhibitors of prenyl-protein transferase (2003-05-20),

2. 6525074 - Inhibitors of prenyl-protein transferase (2003-02-25),

3. 6500841 - Inhibitors of farnesyl-protein transferase (2002-12-31),

4. 6413964 - Inhibitors of prenyl-protein transferase (2002-07-02),

5. 6350755 - Inhibitors of prenyl-protein transferase (2002-02-26),

6. 6316436 - Inhibitors of prenyl-protein transferase (2001-11-13),

7. 6297239 - Inhibitors of prenyl-protein transferase (2001-10-02),

8. 6284755 - Inhibitors of prenyl-protein transferase (2001-09-04),

9. 6127390 - Inhibitors of prenyl-protein transferase (2000-10-03),

10. 6127366 - Inhibitors of farnesyl-protein transferase (2000-10-03),

11. 6054466 - Inhibitors of farnesyl-protein transferase (2000-04-25),

12. 5972984 - Inhibitors of farnesyl-protein transferase (1999-10-26),

13. 5972966 - Inhibitors of farnesyl-protein transferase (1999-10-26),

14. 5939439 - Inhibitors of farnesyl-protein transferase (1999-08-17),

15. 5932590 - Inhibitors of farnesyl-protein transferase (1999-08-03),

As an AI assistant specializing in innovations, inventions, inventors, patent attorneys, assignees, and patents, I can provide you with an article about the renowned inventor, S Jane deSolms.

Title: The Pioneering Work of S Jane deSolms in Inhibitors of Prenyl-Protein Transferase

Introduction: S Jane deSolms, a distinguished inventor based in Norristown, PA (US), has left an indelible mark in the field of pharmaceuticals with his innovative solutions. With an impressive portfolio of 38 patents, his contributions have significantly advanced the realm of chemotherapeutic compositions.

Latest Patents: Among his latest patents is the groundbreaking invention of inhibitors of prenyl-protein transferase. These peptidomimetic macrocyclic compounds play a crucial role in inhibiting prenyl-protein transferase and the prenylation of the oncogene protein Ras, opening new avenues in cancer treatment. His chemotherapeutic compositions showcase his ingenuity in combatting oncogene-related diseases.

Career Highlights: S Jane deSolms has worked with esteemed companies such as Merck & Company, Inc., where he has harnessed his expertise to drive innovation. His dedication to research and development has been instrumental in shaping the pharmaceutical landscape, making him a respected figure in the industry.

Collaborations: Throughout his illustrious career, S Jane deSolms has collaborated with top professionals in the field, including the likes of Samuel L Graham and Anthony W Shaw. Together, they have synergized their talents to pioneer novel solutions in the realm of prenyl-protein transferase inhibitors.

Conclusion: In conclusion, S Jane deSolms stands as a beacon of innovation, with his inventive spirit and unwavering commitment to excellence reshaping the pharmaceutical industry. His legacy will undoubtedly inspire future generations of inventors to push the boundaries of what is possible in the realm of chemotherapeutic advancements.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.